Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 13, 2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire ...
read more
Tuesday, February 13, 2024
Abzena has announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large molecules, which significantly reduces drug development timelines and resource costs...
read more
Tuesday, February 13, 2024
Worldwide Clinical Trials, a global full-service contract research organization (CRO), has released results of a recent industry survey. The report examines changing perceptions about large and midsize CROs within the pharmaceutical and biotech ...
read more
Tuesday, February 13, 2024
Amneal Pharmaceuticals, Inc announced that it has provided a Complete Response resubmission to the FDA for IPX203, a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules for the treatment of Parkinson’s disease (PD).
read more
Tuesday, February 06, 2024
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that Senta Brandt has been promoted to the global position of Head of ...
read more
Tuesday, February 06, 2024
Celerion, a clinical research organization, announced its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.
read more
Tuesday, February 06, 2024
Catawba Research, a global clinical research organization (CRO), announced a new collaboration with Bingli Inc., which provides AI-guided diagnosis, disease management, and navigation for patients and healthcare providers.
read more
Monday, February 05, 2024
mAbxience announced an agreement with Biosidus in which mAbxience will be responsible for the manufacture of the active ingredient Agalsidase Beta, developed by Biosidus as a biosimilar of Fabrazyme.
read more
Monday, February 05, 2024
Greenphire, a provider of software solutions for streamlining clinical trials, announced the acquisition of Clincierge, a provider of concierge travel and logistics support for patients participating in clinical trials.
read more
Thursday, February 01, 2024
Cytomos announced the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser.
read more
Thursday, February 01, 2024
Revenue from Operations grew by 14% YoY both in Q3FY24 and 9MFY24, driven by double digit growth across all the three businesses
read more
Thursday, February 01, 2024
Biovian and 3P Biopharmaceuticals (“3P”), two biologics Contract Development and Manufacturing Organizations (CDMOs), announced their combination to establish a new pan-European leader in their field.
read more
Thursday, February 01, 2024
Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, has proudly announced the acquisition of a wholesale license granted by the New Jersey Department of Health (NJDOH), allowing the company to function as a virtual ...
read more
Wednesday, January 31, 2024
Kindeva Drug Delivery announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device ...
read more
Wednesday, January 31, 2024
AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today ...
read more